Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avoid With Locoregional Analgesia Persistent Postoperative Pain After Surgery In Children
2023-503499-25-00Phase 4Authorised
- Sponsor
- CHU de Nantes
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mepivacaine in postoperative pain, sponsored by CHU de Nantes. Primary endpoint: Persistent postoperative pain at 3 months. Planned start Feb 2024; status: authorised.
02
Drugs
mepivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2023-503499-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503499-25-00.